Recent work on tumor immune microenvironment demonstrated that WHO grading in meningioma negatively correlates with the proportion of CD4+, CD8+, and PD-1+ lymphocytes, along with increased numbers of Treg (FOXP3+) cells in the tumor [16]. This evidence concerns the gene CD4 and neoplasm.